TPBG Recombinant Monoclonal Antibody
-
中文名称:TPBG重组抗体
-
货号:CSB-RA024093MA2HU
-
规格:¥1320
-
图片:
-
其他:
产品详情
-
产品描述:CSB-RA024093MA2HU TPBG重组单克隆抗体是针对人类滋养层细胞糖蛋白(Trophoblast Glycoprotein, TPBG)开发的高特异性科研工具。TPBG是一种高度保守的跨膜蛋白,在胚胎发育、细胞黏附及肿瘤微环境调控中发挥重要作用,其异常表达与多种实体瘤(如结直肠癌、肾细胞癌)的增殖转移密切相关。本抗体采用重组技术制备,经ELISA及流式细胞术(FC)严格验证,在FC应用中推荐使用1:50-1:200稀释比例,可精准识别天然构象下的TPBG抗原表位,具有高灵敏度和低交叉反应特性。适用于肿瘤生物学研究中的细胞表面标记物检测、肿瘤微环境分析、细胞信号转导机制探索以及靶向治疗相关体外实验。该产品通过多批次质控确保稳定性,可配合流式细胞仪、酶标仪等设备开展定量或定性分析,为癌症分子机制研究及抗肿瘤药物开发提供可靠支持,严禁用于临床诊断或治疗相关领域。
-
Uniprot No.:
-
基因名:
-
别名:TPBG Recombinant Monoclonal Antibody
-
反应种属:Human
-
免疫原:Recombinant Human TPBG protein
-
免疫原种属:Homo sapiens (Human)
-
标记方式:Non-conjugated
-
克隆类型:Monoclonal
-
抗体亚型:hIgG1
-
纯化方式:Affinity-chromatography
-
克隆号:9H9
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
产品提供形式:Liquid
-
应用范围:ELISA, FC
-
推荐稀释比:
Application Recommended Dilution FC 1:50-1:200 -
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相关产品
靶点详情
-
功能:May function as an inhibitor of Wnt/beta-catenin signaling by indirectly interacting with LRP6 and blocking Wnt3a-dependent LRP6 internalization.
-
基因功能参考文献:
- In extravillous trophoblasts, 5T4 may function in epithelial-to-mesenchymal transition during placentation. The role of syncytiotrophoblast 5T4 is unknown, but its abundance in shed syncytial vesicles may signify route of sensitization of the maternal immune system. PMID: 28481180
- Collectively, these findings demonstrate that an anti-5T4 antibody-drug conjugate reduces the fraction of cancer stem cells (CSC), and prevents local recurrence and suggest a novel therapeutic approach for patients with head and neck squamous cell carcinoma. PMID: 27780858
- We obtained GWS evidence (P < 2.7 x 10(-6)) for gene-based association in the total sample with a novel locus, TPBG (P = 1.8 x 10(-6)). PMID: 28183528
- In conclusion, the present study provided evidence that TPBG is involved in PDAC metastasis, and that TPBG and its associated signaling pathways may be a suitable target for pancreatic ductal adenocarcinoma therapy. PMID: 25738465
- 5T4 expression is mechanistically associated with the directional movement of cells through epithelial mesenchymal transition, facilitation of CXCL12/CXCR4 chemotaxis, blocking of canonical Wnt/beta-catenin while favouring non-canonical pathway signalling PMID: 25066861
- Tyrosine 325 plus the leucine-rich repeat 1 surface centered on a second exposed aromatic residue, phenylalanine 97, are essential for inhibition of Wnt/beta-catenin signaling. PMID: 24582434
- The surface expression of 5T4 marks the use of the CXCR4 rather than the CXCR7 receptor, with distinct consequences for CXCL12 exposure. PMID: 22956548
- 5T4 is a potential new antigen for targeted therapies such as immunotherapy in MPM, as it is overexpressed on mesothelioma cells and recognised by 5T4-specific cytotoxic T-cells. PMID: 22498111
- Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen PMID: 11903056
- Results sugest that 5T4 is a transient marker of human embryonic stem cell differentiation & that 5T4 phenotype, colony seeding density and culture conditions influence the maintenance of pluripotent hES cells and their differentiation to neural lineages. PMID: 16616918
- there is a repertoire of CD8 T cell recognition of 5T4 in normal human donors and some candidate HLA-A*0201 epitopes have been identified PMID: 16646078
- the mRNA expression of trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia. PMID: 17978129
- 5T4-based cancer vaccine: cytotoxic T lymphocyte epitopes identified in Trovax-vaccinated colorectal cancer patients PMID: 18567615
- colorectal cancer patients who had preexisting cell proliferative responses to 5T4 were longer-term survivors PMID: 18833005
收起更多
-
亚细胞定位:Cell membrane; Single-pass type I membrane protein.
-
组织特异性:Expressed by all types of trophoblasts as early as 9 weeks of development. Specific for trophoblastic cells except for amniotic epithelium. In adult tissues, the expression is limited to a few epithelial cell types but is found on a variety of carcinoma.
-
数据库链接: